Tim Jansen

11.7k citations
205 papers · 9k · 5 hit papers · h-index 44

Impact in

  • Nephrology top 0.05%
    • Gout, Hyperuricemia, Uric Acid
  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments
    • Osteoarthritis Treatment and Mechanisms

Papers in

    • Gout, Hyperuricemia, Uric Acid 88
    • Rheumatoid Arthritis Research and Therapies 54
    • Musculoskeletal synovial abnormalities and treatments 7
    • Spondyloarthritis Studies and Treatments 7

Tim Jansen

199 papers receiving 8.5k citations

Tim Jansen's Hit Papers

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial 2020 · 249 citations
2490+3+7Years since publication4008001.2k

Peers

Tim Jansen
Comparison fields: 5 of 129
  • Nephrology 5k
  • Rheumatology 1.6k
  • Family Practice 44
  • Physiology 378
  • Immunology 242
Replace Frédéric Lioté with:
Frédéric Lioté France
George Nuki United Kingdom
Gail S. Kerr United States
N. Lawrence Edwards United States
Jianghua Chen China
Gert J. Mayer Austria
Joshua F. Baker United States
Susan L. Hogan United States
Piergiorgio Messa Italy
Helen Isobel Keen Australia
Tim Jansen relative to Frédéric Lioté France Frédéric Lioté's profile →
Citations per field
00.5×1.5×
Frédéric Lioté · 1×
Citations per year

Countries citing papers authored by Tim Jansen

Since Specialization
Citations

This map shows the geographic impact of Tim Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Jansen more than expected).

Fields of papers citing papers by Tim Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Jansen. The network helps show where Tim Jansen may publish in the future.

Co-authors

The 25 scholars most cited alongside Tim Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tim Jansen Line = papers co-authored together Tim Jansen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.

#Work
1
2016 updated EULAR evidence-based recommendations for the management of gout
Hit paper breakdown →
20161241
2
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Hit paper breakdown →
2015660
3
2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Hit paper breakdown →
2015498
4 2011398
5
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Hit paper breakdown →
2019313
6
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
Hit paper breakdown →
2020249
7 2015243
8 2012222
9 2011193
10 2014168
11 2011167
12 2007156
13 2008156
14 2008139
15 2013131
16 2014128
17 2015122
18 2015116
19 2016101
20 2019101

About Tim Jansen

Tim Jansen is a scholar working on Nephrology, Rheumatology, Biophysics, Gastroenterology and Physiology, having authored 205 papers that have together received 9k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (88 papers), Rheumatoid Arthritis Research and Therapies (54 papers), Streptococcal Infections and Treatments (10 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers), Musculoskeletal synovial abnormalities and treatments (7 papers), Spondyloarthritis Studies and Treatments (7 papers), Spectroscopy Techniques in Biomedical and Chemical Research (7 papers) and Celiac Disease Research and Management (6 papers). The work is most often cited by research in Nephrology (5k citations), Rheumatology (1.6k citations), Family Practice (44 citations), Physiology (378 citations) and Immunology (242 citations). Tim Jansen has collaborated with scholars based in Netherlands, New Zealand and United States. Frequent co-authors include M. Janssen, Eric Nico van Roon, Fernando Pérez-Ruiz, Jacobus Brouwers, Mart A F J van de Laar, Michael Doherty, Thomas Bardin, Leonardo Punzi, Eliseo Pascual and M.K. Reinders. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical Rheumatology, Lara D. Veeken, The Journal of Rheumatology and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact